Streetbeat News

Earnings

CLMT

Calumet Specialty Products reported Q3 2023 earnings per share (EPS) of $1.26, a significant increase from $0.19 year-over-year (YoY). The company's revenue also beat estimates, coming in at $1.149 billion compared to the estimated $984.263 million.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 2:21 pm

NVAX

Novavax Inc reported Q3 revenue of $187 million, beating the consensus of $158.54 million. The company is on track to exceed its global restructuring and cost reduction plan for 2023 by over $100 million. It also plans to initiate an additional cost reduction program to reduce 2024 expenses by over $300 million. Novavax reduced current liabilities by $128 million during Q3 2023 and by approximately $1 billion as of September 30, 2023. The company sees FY23 revenue of $900 million-$1.1 billion and forecasts Q1 FY24 revenue of $300 million.

Portfolio Pulse from Vandana Singh

November 09, 2023 | 2:20 pm

AMC

AMC Entertainment reported Q3 financial results and announced a $350 million at-the-market offering. This news has led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 2:20 pm

TORO

Toro reported Q3 earnings of $0.79 per share, a 54.9% increase YoY. However, sales decreased by 66.3% to $10.53 million compared to $31.25 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 2:19 pm

WOW

WideOpenWest reported worse-than-expected Q3 sales results, leading to a downgrade of the stock from Overweight to Sector Weight by Keybanc. This has resulted in a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 2:16 pm

STXS

Stereotaxis (AMEX:STXS) reported its Q3 earnings, missing estimated earnings by 16.67% with an EPS of $-0.07 versus an estimate of $-0.06. However, revenue was up $142 thousand from the same period last year. Last quarter, the company also missed on EPS which was followed by a 3.11% drop in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 2:15 pm

ASRT

Assertio Therapeutics reported worse-than-expected Q3 financial results, leading to a drop in its share price.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 2:14 pm

PULM

Pulmatrix reported Q3 losses of $(1.03) per share, beating the analyst consensus estimate of $(1.05) by 1.9 percent. However, the company's quarterly sales of $1.75 million missed the analyst consensus estimate of $1.86 million by 5.75 percent.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 2:14 pm

KRUS

Kura Sushi USA reported mixed Q4 financial results, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 2:14 pm

PUBM

PubMatic reported better-than-expected Q3 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 2:13 pm